Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.eikolifesciences.com | |
Market Cap | 56.09 Cr. | |
Enterprise Value(EV) | 56.80 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.93 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | 72.85 | Trailing Twelve Months Ending 2023-03 |
Industry PE | 29.76 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 35.38 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 1.91 | Calculated using Price: 67.45 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.83 Cr. | 8,316,267 Shares |
FaceValue | 10 | |
About Eiko Lifesciences Ltd. | ||
The company is carrying the business of an investment company and for that purpose to invest in, acquire, sell, transfer, subscribe for, hold and otherwise deal in and invest in any shares, bonds, stocks, obligations issued or guaranteed by any company constituted and carrying on business in India or elsewhere and debentures, debenture-stocks, bonds, obligations and securities issued or guaranteed by any Government, State, Sovereign, Commissioners Central or Provincial, public body or authority supreme, municipal, local or otherwise in India or elsewhere either out of its own funds or out of funds that it might borrow. |
1 Day |
|
-1.17% |
1 Week |
|
-0.25% |
1 Month |
|
-10.66% |
3 Month |
|
-14.10% |
6 Month |
|
+58.84% |
1 Year |
|
+25.78% |
2 Year |
|
-10.60% |
5 Year |
|
+34.58% |
10 Year |
|
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 4.21 | 1.06 | 2.60 | 5.35 | 4.16 | 1.32 | 2.34 | 10.53 | 4.05 | |
Return on Capital Employed (%) | 5.66 | 1.60 | 3.53 | 6.83 | 5.60 | 2.25 | 3.46 | 9.18 | 5.96 | |
Return on Assets (%) | 3.83 | 1.06 | 2.48 | 4.75 | 3.75 | 1.23 | 2.23 | 5.51 | 2.74 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. |
Shh. Funds | 0 | 3 | 3 | 3 | 6 | 5 | 5 | 13 | 29 | 29 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 6 | 1 | ||
Minority Int. | |||||||||||
Equity & Liab. | 0 | 3 | 3 | 4 | 6 | 6 | 6 | 17 | 35 | 31 | |
Non Curr. Assets | 0 | 3 | 3 | 3 | 5 | 5 | 6 | 6 | 22 | 22 | |
Curr. Assets | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 11 | 12 | 9 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 0 | 3 | 3 | 4 | 6 | 6 | 6 | 17 | 35 | 31 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. TTM |
Net Sales | 0 | 0 | 1 | 0 | 0 | 0 | 12 | 25 | 18 | ||
Other Income | 0 | 0 | 0 | 0 | 0 | 1 | 1 | ||||
Total Income | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 12 | 26 | 19 | |
Total Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -11 | -24 | -17 | |
PBIDT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Depreciation | 0 | 0 | 0 | 0 | 0 | -1 | -1 | ||||
Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Exceptional Items | |||||||||||
PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | |
Adjusted EPS | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2 | 1 | 1 |
Particulars | 9 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | 0 | 0 | 0 | 1 | -1 | -8 | |
Cash Fr. Inv. | -3 | 0 | 0 | -1 | 0 | -1 | -3 | 1 | ||
Cash Fr. Finan. | 0 | 3 | 0 | 0 | 2 | 0 | 0 | 8 | 3 | |
Net Change | 0 | 0 | 0 | 1 | -1 | 0 | 4 | -4 | ||
Cash & Cash Eqvt | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 4 | 0 |
Fri, 19 May 2023
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer Revised Announcement. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform that Mr. Avi Vijaykumar Mundecha has tendered his resignation from the post of Company Secretary and Compliance Officer of Eiko Lifesciences Limited (the Company) with effect from close of working hours on May 18 2023. |
Thu, 18 May 2023
Announcement under Regulation 30 (LODR)-Acquisition The Meeting of the Board of Directors of the Company held today i.e. May 18 2023 at 2:00 p.m. the Board inter-alia considered and approved the following. 1. Acquisition of up to 19 20 000 Equity Shares being 25.01% Equity stake in Reflux Pharmaceuticals Private Limited (RPPL) in One or more tranches for a consideration of Rs. 7.008 Crore. (Rupees Seven Crore and Eighty Thousand Only). |
Thu, 18 May 2023
Press Press Release - On execution of Share Subscription Agreement with Reflux Pharmaceuticals Private Limited |
Thu, 08 Jun 2023 |
|
|
|
S Making Lower Lows for 2 Days |
|